INDO has raised its stake in Diamonex CB Medical of Milan from 80.68 to 100 percent. The subsidiary, which employs 20 persons and invoiced more than €2.5 million in 2005, will renamed as INDO Italia. The Spanish company, which now derives 32 percent of its revenues from foreign customers, first acquired a stake of 19.32 percent in Diamonex to provide it with additional resources for the marketing of its own products in Italy.